Taysha Gene Therapies, Inc. TSHA Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s interest coverage?
- Taysha Gene Therapies, Inc. (TSHA) reported interest coverage of -2,501.2× in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s interest coverage changed year-over-year?
- Taysha Gene Therapies, Inc.'s interest coverage decreased by 159.9% year-over-year, from -962.5× to -2,501.2×.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s interest coverage?
- Over 4 years (2021 to 2025), Taysha Gene Therapies, Inc.'s interest coverage has grown at a 95.0% compound annual growth rate (CAGR), from -121.3× to -1,753.9×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.